This Sources Sought opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
RFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Center for Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services is issuing a Request for Information (RFI-MCM-TDRFI-BARDA-2026) to gather market intelligence on current and emerging capabilities for treating drug-resistant fungal infections. This effort aims to inform future acquisition strategies for medical countermeasures that address secondary fungal infections resulting from pandemic influenza, emerging infectious diseases, or chemical, biological, radiological, nuclear, or high-yield explosive (CBRNE) threats. Respondents are expected to provide detailed information on their drug substance and drug product manufacturing processes, including scalability, domestic production capacity, and a plan to onshore both drug substance synthesis and fill-finish operations if currently lacking in the United States. The RFI seeks evidence of a five-year shelf-life for both the drug substance and final drug product, along with comprehensive clinical, nonclinical, and regulatory documentation including Phase 1 through Phase 3 trial designs, FDA correspondence, and a proposed timeline for New Drug Application or supplemental NDA submission. Product delivery options must include either direct delivery to the Strategic National Stockpile or management of vendor-managed inventory by the sponsor. The response must be submitted electronically by June 21, 2026, limited to 12 single-sided pages, and must indicate whether the respondent is registered as a small business. All proprietary information must be clearly marked with restrictive legends; unmarked submissions will be deemed to carry unlimited rights for government use. The solicitation number is MCM TDRFI: BARDA-2026, with NAICS code 541715, and no set aside is in effect. This notice is strictly for planning purposes and does not obligate the government to award a contract, nor does it include pricing, evaluation factors, or formal contract clauses. Point of contact for all inquiries is Audrey Glover and Jonathan Gonzalez, Contracting Officer, at HHS.
General Info
Agency
NAICS
Place of Performance
DC, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Center for the Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Request for Information (RFI) to collect feedback from current and prospective antifungal development partners. Information obtained from this RFI will serve as continued planning for potential future acquisitions and programs. The information collected in response to this RFI is intended to strengthen BARDA’s understanding of the current and future marketplace. This notice seeks information from Other than Small Businesses (OTSB) and Small Businesses (SB) regarding their qualifications, experience, and capabilities.
More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
